C-reactive protein and lactate dehydrogenase serum levels potentially predict the response to checkpoint inhibitors in patients with advanced non-small cell lung cancer

BACKGROUND: Programmed cell death-ligand 1 (PD-L1) expression and other biomarkers are not completely reliable predictors of the response to checkpoint inhibitors in patients with advanced non-small cell lung cancer (NSCLC). We investigated the value of peripheral serological inflammatory indicators...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yilun, Xu, Jinhe, Huang, Xiulian, Xie, Siting, Lin, Ping, Wang, Chenxi, Guo, Yuxin, Zou, Shumei, Zhao, Zhongquan, Wen, Wen, Song, Yingfang, Bao, Zhenming, Zhang, Lei, Liu, Wei, Kong, Wencui, Wang, Wenwu, He, Baochang, Zhang, Shenghang, Zhou, Chengzhi, Chen, Ying, Yu, Zongyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183533/
https://www.ncbi.nlm.nih.gov/pubmed/37197527
http://dx.doi.org/10.21037/jtd-23-240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183533/
https://www.ncbi.nlm.nih.gov/pubmed/37197527
http://dx.doi.org/10.21037/jtd-23-240

Ejemplares similares